Idecabtagene vicleucel Clinical Trials
3 recruitingBiologic
Showing 1–3 of 3 trials
Recruiting
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Non-Hodgkin LymphomaMultiple MyelomaChronic Lymphocytic Leukaemia
Bristol-Myers Squibb50 enrolled8 locationsNCT06357754
Recruiting
The Norwegian Immunotherapy in Multiple Myeloma Study
St. Olavs Hospital400 enrolled23 locationsNCT06855121
Recruiting
A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea
Multiple Myeloma
Bristol-Myers Squibb15 enrolled5 locationsNCT06698887